ArticlePediatric blood & cancer2015

Initial testing (stage 1) of the tubulin binding agent nanoparticle albumin-bound (nab) paclitaxel (Abraxane(®)) by the Pediatric Preclinical Testing Program (PPTP).

Peter J Houghton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.